These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13289853)

  • 1. Failure of synthetic 5-hydroxytryptamine creatinine sulfate to enhance clot retraction of platelet-poor human plasma.
    MAGALINI SI; STEFANINI M
    Proc Soc Exp Biol Med; 1955 Dec; 90(3):615-7. PubMed ID: 13289853
    [No Abstract]   [Full Text] [Related]  

  • 2. [5-Hydroxytryptamine and clot retraction].
    BALLERINI G
    Prog Med (Napoli); 1955 Aug; 11(15):455-6. PubMed ID: 13266901
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF PLASTIC AND GLASS SURFACES ON CLOT RETRACTION AND SEROTONIN UPTAKE OF PLATELET-RICH PLASMA STORED AT 4 DEGREES C.
    OZGE A; BALDINI M; GOLDSTEIN R
    J Lab Clin Med; 1964 Mar; 63():378-93. PubMed ID: 14164492
    [No Abstract]   [Full Text] [Related]  

  • 4. [5-HYDROXYTRYPTAMINE (SEROTONIN) AND CLOT RETRACTION].
    KOVACEVIC Z; MARINKOV S
    Med Pregl; 1964; 17():339-45. PubMed ID: 14309126
    [No Abstract]   [Full Text] [Related]  

  • 5. A plasma factor for platelet adhesiveness and clot retraction acceleration.
    SAVITSKY JP
    Blood; 1953 Dec; 8(12):1091-8. PubMed ID: 13105710
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
    Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
    Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine platelets, serotonin and the retraction of bovine plasma clots.
    FENICHEL RL; SEEGERS WH
    Am J Physiol; 1955 Apr; 181(1):19-20. PubMed ID: 14376561
    [No Abstract]   [Full Text] [Related]  

  • 8. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
    Lockhart MS; Comp PC; Taylor FB
    J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dialyzable factor from plasma responsible for the viscous metamorphosis of the blood platelets; its role in clot retraction and haemostasis.
    LUSCHER EF
    Experientia; 1956 Jul; 12(7):268-70. PubMed ID: 13344444
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet adhesiveness and clot-retraction time.
    SAVITSKY JP; WERMAN R
    Am J Clin Pathol; 1952 Dec; 22(12):1175-80. PubMed ID: 12996467
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE PLATELET EQUIVALENT VALUE AND DEGREE OF RETRACTION AS A MEASUREMENT FOR THE COMPARATIVE STUDY OF CLOT RETRACTION].
    KUHNKE E; BRILLA G
    Thromb Diath Haemorrh; 1964 Apr; 11():210-21. PubMed ID: 14167104
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the metabolism of human blood platelets in relation to clot retraction.
    BETTEX-GALLAND M; LUSCHER EF
    Thromb Diath Haemorrh; 1960 Mar; 4():178-95. PubMed ID: 13800197
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diurnal variations of the platelet count and its effect in clot retraction].
    MATIS P; GROSS R
    Schweiz Med Wochenschr; 1951 Oct; 81(42):1043-5. PubMed ID: 14883834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 5-hydroxytryptamine (serotonin), 5-hydroxytryptophan & serotonin antagonists on clot retraction].
    GROSS R; STAUFENBERG E
    Thromb Diath Haemorrh; 1958 May; 2(1-2):125-39. PubMed ID: 13581020
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of thrombin and platelet concentrations and of clot retraction on fibrin strand widths.
    GREENE RW
    J Clin Invest; 1955 Mar; 34(3):417-27. PubMed ID: 14354011
    [No Abstract]   [Full Text] [Related]  

  • 17. Thrombocytopenia with a circulating platelet agglutinin, platelet agglutinin, platelet lysin and clot retraction inhibitor.
    ZUCKER MB; LEY AB; BORRELLI J; MAYER K; FIRMAT J
    Blood; 1959 Feb; 14(2):148-61. PubMed ID: 13618372
    [No Abstract]   [Full Text] [Related]  

  • 18. Separable function of platelet release reaction and clot retraction.
    Yatomi Y; Higashihara M; Tanabe A; Ohashi T; Takahata K; Kariya T; Kume S
    Biochem Biophys Res Commun; 1986 Oct; 140(1):329-34. PubMed ID: 3022719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet size, ATP content, and clot retraction in relation to platelet age.
    DETWILER TC; ODELL TT; MacDONALD TP
    Am J Physiol; 1962 Jul; 203():107-10. PubMed ID: 13885826
    [No Abstract]   [Full Text] [Related]  

  • 20. Peroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production.
    Misztal T; Rusak T; Tomasiak M
    Thromb Res; 2014 Mar; 133(3):402-11. PubMed ID: 24388569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.